Brixadi Monthly injection

Generic name: Buprenorphine (injection)

Usage of Brixadi Monthly injection

This medication guide provides information about Brixadi Monthly brands used only to treat opioid addiction in adults. These brands are not to be used as pain medication.

Brixadi Monthly is given to people who have started opioid addiction treatment with a form of Buprenorphine placed under the tongue or inside the cheek.

Brixadi Monthly is available only under a special program. You must be registered in the program and understand the risks and benefits of Brixadi Monthly.

Brixadi Monthly may also be used for purposes not listed in this medication guide.

Brixadi Monthly injection side effects

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

Opioid medicine can slow or stop your breathing, and death may occur. A person caring for you should give naloxone and/or seek emergency medical attention if you have slow breathing with long pauses, blue colored lips, or if you are hard to wake up.

Brixadi Monthly may cause serious side effects. Call your doctor at once if you have:

  • weak or shallow breathing, breathing that stops;
  • severe drowsiness or dizziness, loss of coordination;
  • a light-headed feeling, like you might pass out;
  • opioid withdrawal symptoms--shivering, goose bumps, increased sweating, feeling hot or cold, runny nose, watery eyes, diarrhea, vomiting;
  • liver problems--loss of appetite, stomach pain (upper right side), tiredness, itching, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes); or
  • decreased adrenal gland hormones--nausea, vomiting, stomach pain, loss of appetite, feeling tired or light-headed, muscle or joint pain, skin discoloration, craving salty foods.

    • Seek medical attention right away if you have symptoms of serotonin syndrome, such as: agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, or diarrhea.

    Tell your doctor right away if you develop withdrawal symptoms or an allergic reaction even weeks or months after your last dose of buprenorphine injection.

    Common side effects of Brixadi Monthly may include:

  • feeling tired;
  • nausea, vomiting, constipation;
  • pain, redness, itching, burning, irritation, or skin changes where the injection was given;
  • pain and burning when you urinate;
  • trouble sleeping;
  • headache; or
  • abnormal liver function tests.

    • This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    Before taking Brixadi Monthly injection

    You should not be treated with Brixadi Monthly if you are allergic to it.

    Tell your doctor if you also use stimulant medicine, opioid medicine, herbal products, or medicine for depression, mental illness, Parkinson's disease, migraine headaches, serious infections, or prevention of nausea and vomiting. An interaction with Brixadi Monthly could cause a serious condition called serotonin syndrome.

    Tell your doctor if you have or have ever had:

  • breathing problems, sleep apnea;
  • a head injury or brain problem;
  • alcoholism, mental illness;
  • an allergy to latex;
  • an enlarged prostate;
  • urination problems;
  • heart problems;
  • an electrolyte imbalance (such as low blood levels of potassium or magnesium);
  • curvature of the spine that affects breathing;
  • Addison's disease (or any other adrenal gland problem);
  • problems with your gallbladder or thyroid; or
  • liver or kidney disease.

    • Brixadi Monthly may affect fertility in men or women. Pregnancy could be harder to achieve while either parent is using this medicine.

    If you use Brixadi Monthly during pregnancy, your baby could be born with life-threatening withdrawal symptoms, and may need medical treatment for several weeks. Tell your doctor if you are pregnant or plan to become pregnant.

    Tell your doctor if you are breastfeeding. If you are breastfeeding, tell your doctor if you notice severe drowsiness or slow breathing in the nursing baby.

    How to use Brixadi Monthly injection

    Brixadi Monthly is injected under the skin. A healthcare provider will give you this injection.

    After each injection, you may see or feel a small lump under your skin where the medicine was injected. This could last for several weeks but the lump should eventually get smaller. Avoid rubbing or massaging the skin where an injection was given and wearing tight clothing over the area.

    Your doctor will determine how often you will receive Brixadi Monthly.

    You will need frequent blood tests to check your liver function.

    Brixadi Monthly is only part of a complete treatment program that may also include counseling and other types of addiction support. Tell your doctor if you feel that Brixadi Monthly is not helping to improve your symptoms of addiction.

    In an emergency, your family or caregivers should tell medical personnel that you are using Brixadi Monthly. Make sure any follow-up doctor knows you use this medicine.

    Do not stop using Brixadi Monthly suddenly, or you could have unpleasant symptoms (such as agitation, confusion, tingling or electric shock feelings).

    Warnings

    Fatal side effects may occur if you also drink alcohol or use other drugs that cause drowsiness or slow breathing.

    Using opioid medicine during pregnancy may cause life-threatening withdrawal symptoms in the newborn.

    Brixadi Monthly is available only under a special program. You must be registered in the program and understand the risks and benefits of Brixadi Monthly.

    What other drugs will affect Brixadi Monthly injection

    Sometimes it is not safe to use certain medicines at the same time. Some drugs can affect your blood levels of other drugs you use, which may increase side effects or make the medicines less effective. Tell your doctor if you also use an antibiotic, antifungal medication, seizure medication, or medicine to treat HIV or hepatitis C.

    Many other drugs can be dangerous when used with opioid medicine. Tell your doctor if you also use:

  • medicine for allergies, asthma, heart problems, motion sickness, irritable bowel, or overactive bladder;
  • other opioid medicines;
  • a benzodiazepine sedative like Valium, Klonopin, or Xanax;
  • sleep medicine, muscle relaxers, or other medications that make you drowsy; or
  • medications that affect serotonin, such as antidepressants, stimulants, or medicine for migraines or Parkinson's disease.

    • This list is not complete and many other drugs may affect Brixadi Monthly. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

    Popular FAQ

    How long opioid withdrawal lasts depends on the opioid you have been taking and whether it is a short-acting or long acting opioid. If you have been using a short-acting opioid, acute opioid withdrawal lasts 4 to 10 days, with withdrawal symptoms starting 8 to 24 hours after last use. If you have been using a long-acting opioid, acute opioid withdrawal lasts 10 to 20 days, with withdrawal symptoms starting 12 to 48 hours after last use. Continue reading

    After one sublingual or buccal dose, buprenorphine stays in your system for about 5 to 8 days if you are healthy or 7 to 12 days if you have liver disease. Continue reading

    It is available in a number of dosage forms under the brand names Sublocade, Brixadi, Probuphine (discontinued), Belbuca, Butrans, Buprenex, and Subutex (discontinued). Continue reading

    Sublocade and Brixadi are both subcutaneous long-acting buprenorphine injections that may be used for the maintenance treatment of opioid misuse disorder in adults. Sublocade was approved on November 30, 2017, and Brixadi was approved on May 23, 2023. Sublocade is administered once a month, with a minimum of 26 days between doses. If extended travel is deemed necessary, a single 300mg injection may be given to cover 2 months. Brixadi is given once a week or once a month. Continue reading

    Buprenorphine and naloxone is a combination medicine used for the maintenance treatment of opioid dependence in adults. It is available in sublingual film and sublingual tablet dosage forms under the brand names Suboxone, Zubsolv, Bunavail (discontinued), and Cassipa (discontinued). Continue reading

    There is no one-size-fits-all treatment duration for patients taking buprenorphine. There are many factors involved in determining the length of treatment when administering buprenorphine. Continue reading

    Yes, Buprenex is the brand name for an injectable form of buprenorphine. Buprenex (generic name: buprenorphine) is a potent opioid (narcotic) medication used to manage pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate. Continue reading

    How long opioid withdrawal lasts depends on the opioid you have been taking and whether it is a short-acting or long acting opioid. If you have been using a short-acting opioid, acute opioid withdrawal lasts 4 to 10 days, with withdrawal symptoms starting 8 to 24 hours after last use. If you have been using a long-acting opioid, acute opioid withdrawal lasts 10 to 20 days, with withdrawal symptoms starting 12 to 48 hours after last use. Continue reading

    After one sublingual or buccal dose, buprenorphine stays in your system for about 5 to 8 days if you are healthy or 7 to 12 days if you have liver disease. Continue reading

    It is available in a number of dosage forms under the brand names Sublocade, Brixadi, Probuphine (discontinued), Belbuca, Butrans, Buprenex, and Subutex (discontinued). Continue reading

    Sublocade and Brixadi are both subcutaneous long-acting buprenorphine injections that may be used for the maintenance treatment of opioid misuse disorder in adults. Sublocade was approved on November 30, 2017, and Brixadi was approved on May 23, 2023. Sublocade is administered once a month, with a minimum of 26 days between doses. If extended travel is deemed necessary, a single 300mg injection may be given to cover 2 months. Brixadi is given once a week or once a month. Continue reading

    Buprenorphine and naloxone is a combination medicine used for the maintenance treatment of opioid dependence in adults. It is available in sublingual film and sublingual tablet dosage forms under the brand names Suboxone, Zubsolv, Bunavail (discontinued), and Cassipa (discontinued). Continue reading

    There is no one-size-fits-all treatment duration for patients taking buprenorphine. There are many factors involved in determining the length of treatment when administering buprenorphine. Continue reading

    Yes, Buprenex is the brand name for an injectable form of buprenorphine. Buprenex (generic name: buprenorphine) is a potent opioid (narcotic) medication used to manage pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate. Continue reading

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords